O receptor canabinoide CB1, altamente expresso em várias regiões do sistema límbico, possui um importante papel na regulação da plasticidade sináptica implicada nas diferentes fases da memória emocional. Em roedores, embora já estejam bem caracterizados os efeitos da manipulação farmacológica do receptor CB1 na amígdala, no hipocampo e no córtex pré-frontal medial sobre a modulação de memórias aversivas, sua função no córtex retrosplenial (RSC) permanece desconhecida. Neste trabalho, usando o paradigma pavloviano de condicionamento aversivo ao contexto em ratos, exploramos o papel do sistema canabinoide no RSC sobre as fases de consolidação, reconsolidação e extinção da memória. Demostramos que a infusão intra-RSC imediatamente pós-treino de AM251 (11 μg/μL), um antagonista seletivo CB1, causa amnésia retrógrada no teste de retenção da memória conduzido 48 h após o condicionamento, enquanto que a infusão bilateral de CP55940, um agonista canabinoide CB1/CB2 (5μg/μL), facilita a consolidação da memória. No protocolo de reconsolidação (injeção intra-RSC após uma sessão de reativação de 4 min, conduzida 48 h depois do condicionamento) foram encontramos efeitos opostos no teste de retenção da memória realizado 24 h após a reativação: o bloqueio dos receptores CB1 facilita, enquanto que sua ativação prejudica o fenômeno de reconsolidação da memória. Além disso, quando o AM251 é injetado intra-RSC 20 min antes de uma reexposição prolongada (de 30 min), observamos que a consolidação da memória de extinção é prejudicada, enquanto que o CP55940 acelera a extinção e impede sua recuperação espontânea ao longo do tempo. Concluindo, nossos resultados apresentam novas evidências sobre a função do sistema canabinoide no RSC sobre a modulação das fases de consolidação, reconsolidação e extinção da memória emocional. / The CB1 cannabinoid receptor is highly expressed in many regions of the limbic system, having an important role in the regulation of synaptic plasticity implicated in different phases of emotional memory processing. In rodents, although are well characterized the effects of the pharmacological manipulations of the CB1 receptor in the amygdala, hippocampus, and medial prefrontal cortex upon the modulation of aversive memories, their function in the retrosplenial cortex (RSC) remains unknown. In this study, using pavlovian contextual fear conditioning in rats, we explored the role of the cannabinoid system in the RSC on memory consolidation, reconsolidation, and extinction. We showed that posttraining intra-RSC infusion of AM251 (11 μg/μL), a selective CB1 antagonist, causes retrograde amnesia during the test for memory retention conducted 48 h after learning, whereas the bilateral infusion of CP55940 (5 μg/μL), a CB1/CB2 agonist, enhanced fear memory consolidation. In the reconsolidation protocol (postreactivation intra-RSC infusions conducted 48 h after training) we found opposite effects in the test session performed 24 h after memory reactivation: blocking CB1 receptors enhanced, whereas the activation of cannabinoid receptors impaired memory reconsolidation. Furthermore, when AM251 was infused intra-RSC 20 min before a prolonged reexposure (30 min), memory extinction was impaired, whereas the infusion of CP55940 accelerates memory extinction and prevents spontaneous recovery, maintaining memory extinguished over time. In conclusion, these data shed new light about the function of the cannabinoid system in the RSC on the role of contextual-fear related memory consolidation, reconsolidation, and extinction.

Previous exposure to the training context disrupts glutamatergic N-methyl-Daspartate receptor (NMDAr) antagonist-induced amnesia, indicating that novelty is necessary for such an amnestic effect. While there are reports that novelty-related release of opioids cause amnesia, no study has addressed whether the amnestic effect of NMDAr antagonists involve opioid mechanisms. In this study we investigated whether pharmacological manipulation of the opioid system immediately after context pre-exposure alters the amnestic effect of arcaine, a NMDAr antagonist. Adult male Wistar rats were habituated (pre-exposed) to a fear conditioning training apparatus or to a different context (open field). Immediately after pre-exposure, animals were injected with saline or naloxone (0.5 mg/kg, i.p.) or anti-beta-endorphin antibody (1:500, i.c.v.). Forty eight hours after pre-exposure session, all animals were subjected to fear conditioning acquisition protocol and saline or arcaine (30 mg/kg, i.p.) was administered immediately after training. Testing was carried out 24 h later, and freezing responses due to re-exposure to the training apparatus were recorded. Pre-exposure to the training apparatus prevented the impairment of memory induced by post-training arcaine. Administration of naloxone or anti-beta-endorphin antibody, immediately after pre-exposure to the training apparatus, reinstated the amnesic effect of post-training arcaine. The results suggest that endogenous opioid mechanisms are involved in the pre-exposure-induced loss of the amnestic effect of arcaine. / A exposição prévia ao ambiente de treinamento prejudica o efeito amnésico de antagonistas do receptor NMDA, indicando que a presença de novidade é necessária para se observar efeitos amnésicos. Embora haja estudos mostrando que a presença de novidade induz a liberação de opióides endógenos e esses induzem amnésia, nenhum estudo procurou abordar se o efeito amnésico induzido por antagonistas NMDA envolve mecanismos opióides. Neste estudo foi investigado se a manipulação farmacológica do sistema opióide imediatamente após a préexposição ao contexto do treino altera o efeito amnésico induzido por arcaína, um antagonista do receptor NMDA. Ratos Wistar machos adultos foram habituados (préexpostos) ao mesmo contexto de treinamento ou em um contexto diferente ao de treinamento (campo aberto). Imediatamente após a pré-exposição, os animais receberam injeções de salina ou naloxona (0,5 mg/kg, i.p.) ou anticorpo anti-beta endorfina (1:500, i.c.v.). Quarenta e oito horas depois da sessão de pré-exposição, todos os animais foram submetidos ao treino do medo condicionado contextual e imediatamente após o treino foi administrado salina ou arcaína (30 mg/kg, i.p.). A sessão de teste foi realizada vinte e quatro horas após a sessão de treino e a imobilidade do animal foi analisada como um parâmetro de memória de medo dos animais. A pré-exposição ao aparato de treinamento preveniu o déficit de memória induzido pela administração pós-treino de arcaína. A administração de naloxona ou anticorpo anti-beta endorfina imediatamente após a pré-exposição ao aparato de treinamento restabeleceu o efeito amnésico da administração pós-treino de arcaína. Esses resultados sugerem que o efeito amnésico da arcaina depende da novidade e do sistema opióide.

A l’heure actuelle, une des principales questions des neurosciences comportementales est de comprendre les bases neurales des apprentissages et de comprendre comment des modifications au sein de circuits neuronaux spécifiques contrôlent les changements comportementaux liés à une expérience particulière. De nombreuses études ont récemment mis en évidence le rôle important des circuits neuronaux dans les phénomènes d’apprentissages associatifs, et notamment dans la régulation des comportements de peur. Cependant, leurs caractéristiques anatomiques et fonctionnelles restent encore largement inconnues. L’une des principales fonctions des circuits neuronaux est leur capacité à adapter le comportement en fonction de la nature des informations internes ou environnementales disponibles. Malgré de nombreux progrès réalisés sur la compréhension des substrats et mécanismes neuronaux sous tendant le conditionnement de peur au sein de structures telles que l'amygdale (AMG), le cortex préfrontal dorso-médian (dmPFC) et la substance grise periaqueducale (PAG), les mécanismes neuronaux gouvernant les interactions inter-structure ainsi que le contrôle local de ces différents circuits neuronaux restent encore largement inconnus. Dans ce contexte, ce travail de thèse a eupour objectifs principaux, d’évaluer la contribution des voies de projections dmPFC-BLA et dmPFC-vlPAG dans la régulation des comportements de peur, et, d’identifier les mécanismes neuronaux sous-jacent contrôlant l'expression de la peur. Afin de répondre à ces questions, nous avons utilisé conjointement des enregistrements électrophysiologiques unitaires et de potentiels de champs couplés à des approches optogénétiques au cours de l’expression de la peur conditionnée. Nous avons pu mettre en évidence un nouveau mécanisme neuronal basé sur une oscillation cérébrale à 4 Hz entre le dmPFC et le BLA impliqué dans la synchronisation neuronale des neurones de ces deux structures nécessaire à l’expression de la peur. Nous avons aussi démontré que le dmPFC via ses projections sur le vlPAG contrôle directement l’expression de la peur. Ensemble, nos données contribuent à une meilleure compréhension des circuits neuronaux ainsi que des mécanismes du comportement de peur qui dans le futur pourront aider à une amélioration thérapeutique des troubles anxieux. / A central endeavour of modern neuroscience is to understand the neural basis of learningand how the selection of dedicated circuits modulates experience-dependent changes inbehaviour. Decades of research allowed a global understanding of the computations occurring inhard-wired networks during associative learning, in particular fear behaviour. However, brainfunctions are not only derived from hard-wired circuits, but also depend on modulation of circuitfunction. It is therefore realistic to consider that brain areas contain multiple potential circuitswhich selection is based on environmental context and internal state. Whereas the role of entirebrain areas such as the amygdala (AMG), the dorsal medial prefrontal cortex (dmPFC) or theperiaqueductal grey matter (PAG) in fear behaviour is reasonably well understood at themolecular and synaptic levels, there is a big gap in our knowledge of how fear behaviour iscontrolled at the level of defined circuits within these brain areas. More particularly, whereas thedmPFC densely project to both the basolateral amygdala (BLA) and PAG, the contributions ofthese two projections pathway during fear behaviour are largely unknown. Beside theinvolvement of these neuronal pathways in the transmission of fear related-information, theneuronal mechanisms involved in the encoding of fear behaviour within these pathways are alsovirtually unknown. In this context, the present thesis work had two main objectives. First,evaluate the contribution of the dmPFC-BLA and dmPFC-vlPAG pathways in the regulation offear behaviour, and second, identify the neuronal mechanisms controlling fear expression in thesecircuits. To achieve these goals, we used a combination of single unit and local field potentialrecordings coupled to optogenetic approaches in behaving animals submitted to a discriminativefear conditioning paradigm. Our results first, identified a novel neuronal mechanism of fear expression based on the development of 4 H oscillations within dmPFC-BLA circuits thatdetermine the dynamics of freezing behaviour and allows the long-range synchronization offiring activities to drive fear behaviour. Secondly, our results identified the precise circuitry at thelevel of the dmPFC and vlPAG that causally regulate fear behaviour. Together these data provideimportant insights into the neuronal circuits and mechanisms of fear behaviour. Ultimately thesefindings will eventually lead to a refinement of actual therapeutic strategies for pathological conditions such as anxiety disorders.

Les désordres intellectuels (DI) comprennent une collection hétérogène de désordresneurodéveloppementaux qui émergent pendant l’enfance. Ils ont une incidence de 1 à 3% dansla population et sont associés avec des déficits dans les fonctions mentales et adaptives. Denombreuses mutations ont été identifiées dans des gènes codant pour des protéines quiremplissent des fonctions biologiques très diverses dans le cerveau. Parmi ces protéines,certaines sont enrichies à la synapse, supposant que les déficits cognitifs associés aux DIpourraient être reliés à des déficits synaptiques. L’objectif scientifique de notre équipe et decomprendre le rôle de certaines protéines dans la fonction synaptique et la cognition enutilisant des souris génétiquement modifiées portant des mutations dans le gènecorrespondant. Je me suis concentré sur Il1rapl1, un gène codant pour la protéine Interleukinreceptor-accessory-protein-like-1. Des mutations ou micro-délétions dans ce gène sont liés audéveloppement de DI chez l’homme. Dans les neurones, Il1rapl1 code pour une protéinetransmembranaire qui serait impliquée dans la formation et/ou la stabilisation de synapsesexcitatrices. Les conséquences de l’absence d’IL1RAPL1 à des niveaux plus intégrés restaientpeu étudiées lors du début de ma thèse. J’ai utilisé une souris déficiente pour IL1RAPL1 (KO) afinde comprendre le lien entre les déficits comportementaux et la fonction synaptique. Pour cela,j’ai soumis des souris KO à des taches comportementales de peur conditionnée. J’ai ensuiteutilisé une combinaison d’approches in vitro, ex vivo et in vivo afin de caractériser la fonctionsynaptique dans les circuits neuronaux dédiés : l’amygdale latérale et basolatérale. Desenregistrements electrophysiologiques ont montré une dérégulation de la balance entre latransmission inhibitrice et excitatrice (I/E) dans l’amygdale de souris Il1rapl1 KO, causant ainsides déficits dans la capacité d’acquérir et d’exprimer la mémoire de peur conditionnée. Lacorrection de ce déficit synaptique in vivo par pharmacologie ou par optogénétique a permis derestaurer le comportement chez les souris KO. / Intellectual disability (ID) comprises a highly heterogeneous collection of neurodevelopmentaldisorders that arise during childhood. They have an incidence of 1-3% in the population withimpairments in mental and adaptive functions. While the etiologies of IDs are thought to bevery heterogeneous, a significant proportion of ID has genetic origins. Mutations in single IDgenes lead to dysfunctions in proteins that fulfill highly different biological functions in thebrain. Interestingly, ID-related proteins are often found enriched at synapses, suggesting thatcognitive impairments defining ID could be related to alterations of synaptic function. The maingoal of our research team is to understand the role of ID-related proteins in synaptic functionand cognition using mouse models bearing gene mutations associated to ID in humans. Myresearch focused on the study of Il1rapl1, a gene coding for the Interleukin-receptor-accessoryprotein-like-1 protein. Micro-deletions or point mutations in this gene are directly linked to thedevelopment of ID and autism spectrum disorder in humans. In neurons, Il1rapl1 encodes atrans-membrane protein and several in vitro experiments point to its important role in thedifferentiation and formation/stabilization of excitatory synapses trough interactions withpresynaptic, trans-synaptic or postsynaptic partners. However, the consequences of Il1rapl1deficiency at more integrated levels remains poorly understood. The principal objective of mythesis is to explore the link between synaptic deficits and behavioral impairments in Il1rapl1-deficient mice. To achieve that, wild-type and mutant animals were first submitted to fearlearning tasks. I then used a combination of in vivo, ex vivo and in vitro functional essays tocharacterize synaptic functions in behaviorally relevant neuronal circuits. Ultimately, ourworking hypothesis were challenged in vivo by pharmacological and optogenetic approaches tonormalize behavioral deficits in Il1rapl1 KO mice. Altogether my work demonstrates thatInhibitory/Excitatory imbalances associated with the absence of Il1rapl1 impaired both thecapacity to form new memories as well as the expression of previously formed memories.

Insomnia is one of the most common health issues, with occasional symptoms affecting up to 50% of the general population. Lack of sleep is associated with many negative health effects. A new evolutionary hypothesis has been proposed to explain the mechanism behind insomnia symptoms. The evolutionary-emotional hypothesis proposes that while acute insomnia might be advantageous from an evolutionary perspective, chronic insomnia is maladaptive and may follow from a failure or delay of fear extinction. The aim of the current thesis was to investigate which neural mechanisms might be at work if one is to consider the evolutionaryemotional hypothesis about the causes of insomnia plausible and to review studies from cognitive neuroscience to discover what support there might be for the hypothesis. Studies have found heightened activation in fear-related brain areas in insomnia patients. Delayed fear extinction and altered emotion regulation circuitry, among other things, were also observed for insomnia patients. However, few experimental studies on the effect of fear extinction on sleep in insomnia patients have been conducted. At this time, some emerging evidence lends support for the evolutionary-emotional hypothesis of insomnia, but more studies that directly assess fear conditioning and fear extinction processes in insomnia patients are needed to assess the explanatory power of the theory.

A multitude of factors, that either singly, interactively, or sequentially influence the gene-environment interplay in affective and dementia states, include several phases of neurodevelopmental liability in both humans and laboratory animals. Genetic vulnerability for both affective disorders and dementia describes a scenario distinguished by progressive need for concern, particularly in view of the interplay between these areas of ill-health. The contribution of emotional and cognitive expression to personal outcomes, e.g., as a function of affective personality type, a state-dependent analysis of personality characteristics, appears to pervade both the individual's experience of social and physical environments and the performance of cognitive tasks. The role of the endocannabinoids in mental health may offer insights for the psychopharmacology of both cognition and affect. Maladaptive emotional reactions and a defective cognitive ability will contribution to unsatisfactory/maladaptive coping strategies, in turn, leading to further complications of an affective and dysfunctional nature, eventually with a clinical psychopathological outcome. These considerations impinge upon critical issues concerning predisposition and vulnerability. Classical eye-blink conditioning provides a highly established procedure for assessment of defective physiology in models of Alzheimer's dementia. In order to develop a consideration of the array of situations presenting the variation of outcome due to type of affective personality, the role of fear and anxiety and stress in affective states influencing cognition are examined and the critical role of brain circuits mediating emotions influencing cognitive outcomes is discussed.

Classical fear conditioning – including acquisition and extinction – is a model for fear learning and memory in health and disease. Moreover, trauma-related disorders can be viewed as comprising fear acquisition under severe stress. Yet, in humans, we know comparatively little about how acute stress affects fear conditioning. Therefore, the first aim of this thesis was to investigate the effect of stress on fear acquisition or extinction. Stress induces multiple hormonal and neurotransmitter changes dynamically developing over time, including a fast first-wave and a slower second-wave stress response. Models derived from avoidance learning and declarative memory studies suggest that stress effects on memory depend on the temporal proximity between learning and stressor: encoding close to the stressor will be enhanced, but encoding and recall later in time (during the second-wave) will be suppressed (e.g., Schwabe, Joëls, Roozendaal, Wolf, & Oitzl, 2012). So far, these predictions were not related to fear conditioning. Therefore, we investigated if the model-based predictions are also valid in human fear conditioning. We used two stressors to investigate first-wave and second-wave stress effects: the cold pressor test (CPT) inducing a strong first-wave but little second-wave activation and a psychosocial stressor, reliably inducing both, first- and second-wave stress responses. Conditioning was measured via skin conductance responses (SCRs). Investigating the first-wave (Experiment 2), we placed fear acquisition and immediate extinction directly after the CPT (n = 20) or after the control treatment (n = 20). We found no group difference in acquisition performance, but significantly increased extinction resistance in the stressed CPT group. In Experiment 3, CPT (n = 20) or control (n = 20) was placed after acquisition but directly prior to extinction training. Here, we found improved extinction and 24h-delayed extinction recall after CPT. Investigating the second-wave (Experiment 1), we placed fear acquisition and immediate extinction 45 min after the psychosocial stressor (i.e., at the peak of salivary cortisol, n = 12) or after control (n = 12). Here, we found no significant stress effects. Sex and female sex hormones also influence fear conditioning: Women are at a higher risk to develop anxiety and stressor-related disorders than men. Interestingly, patients with these disorders show impaired fear extinction and extinction recall, and low levels of the sex hormone 17β-estradiol (E2) are linked to impaired extinction in both, healthy and patient female samples. So far, there is little data on how acute stress and circulating E2-levels might interact in fear acquisition and especially in fear extinction. Therefore, the second aim of this thesis was to explore this possible interaction in healthy women in different cycle phases compared to men. Thus, in Experiment 4, we included hormone status as a quasi-experimental variable and compared free cycling women in the midcycle phase (high E2, low progesterone, n = 24), women in the early follicular phase of the menstrual cycle (low E2, low progesterone, n = 24), and men (n = 24). We placed fear acquisition and extinction 45 min after the psychosocial stressor (n = 36) or control (n = 36), and tested extinction recall after 24 h. In line with Experiment 1, the second-wave stressor did not affect fear acquisition and immediate extinction. However, we found a stress by hormone status interaction within women at the 24h-delayed extinction recall test: in the stressed group, early follicular women showed impaired extinction recall and a higher return of fear compared to midcycle women, whereas there was no difference between early follicular and midcycle women after control treatment. Collectively our results support a different role for the first- and second-wave stress response in human fear conditioning. Fear acquisition near the first-wave stress response results in enhanced fear memory, which is resistant to extinction. Extinction training near the first-wave enhances extinction learning. In contrast, fear conditioning at the peak of the peripheral second-wave cortisol response had no effect on acquisition or extinction performance. However, second-wave stress interacted with the hormone status of women, where only women in a low E2 state were vulnerable to negative stress effects in extinction recall. The last result will encourage further investigation of the interplay between E2 and stress in fear extinction. Enhancement of extinction by the CPT could – if replicated – be translated into strategies for optimizing exposure therapy.

No description available.

No description available.

[pt] A matéria cinzenta periaquedutal dorsal (MCPD) é associada com comportamento defensivo e ataques de pânico em humanos. Estimulações elétricas ou farmacológicas da MCPD induzem a reações aversivas de corrida e pulo em ratos. Os resultados no experimento 1 indicaram que animais submetidos a um contexto previamente associado com choques nas patas, obtiveram um comportamento defensivo de congelamento robusto e tiveram menores reações defensivas de corridas e pulos através da microinjeção de de 0.3 µl N-metil-D- aspartato (NMDA; 15.0 mg/kg), quando comparado com o grupo controle que não foi exposto ao procedimento de medo ao contexto. No experimento 2, o efeito de injeções de pentilenotetrazol (PTZ; 15.0 mg/kg i.p.) em ratos microinjetados com NMDA nas reações de corridas e pulos foi investigado. Os resultados mostraram que o PTZ (1ml/100gr) foi capaz de minimizar as reações aversivas de corridas e pulos induzidas pela microinjeção de NMDA na MCPD. Esses resultados sugerem que a ativação de mecanismos cerebrais que permeiam a ansiedade produzem um efeito inibitório em ataques de pânico. / [en] The dorsal portion of the periaqueductal gray (DPAG) is notably associated with defensive behavior and panic attacks in humans. Electrical or pharmacological stimulation of the DPAG induces aversive reactions such as running and jumping in rats. Our results indicate that animals exposed to contextual cues, that were previously associated with electrical footshocks, engaged in robust defensive freezing behavior and were less likely to display running and jumping defensive reactions by microinjection of 0.3 µl N-methyl-D-aspartate (NMDA; 15.0 mg/kg) into DPAG when compared with control animals that were not exposed to the context fear conditioning procedure. Furthermore the effect of pentylenotetrazole injections (PTZ; 15.0 mg/kg i.p.) in microinjected NMDA rats in aversive reactions of running and jumping was investigated. The result showed that PTZ dose (1ml/100gr) was capable to minimize the aversive reactions of running and jumping induced by microinjection of NMDA into DPAG. These results suggest that activation of the brain mechanisms that underlie anxiety produces an inhibitory effect on panic attacks.